Stephen John Palmer

Filter

2024

Challenges, considerations, and approaches for developing a cost-effectiveness model for the adjuvant treatment of muscle-invasive urothelial carcinoma: with a spotlight on nivolumab versus placebo
Teitsson, S., Brodtkorb, T. H., Kurt, M., Patel, M. Y., Poretta, T., Knight, C., Kamgar, F. & Palmer, S., 25 Mar 2024, In: Journal of Medical Economics. 27, 1, p. 473-481 9 p.
Research output: Contribution to journal › Letter › peer-review

Open Access
File
2019

Time horizons in cost analyses
Majer, I. M., Kumar, S. K. & Palmer, S., 13 Aug 2019, In: JAMA - Journal of the American Medical Association. 322, 6, p. 582-583 2 p.
Research output: Contribution to journal › Letter › peer-review
2012

The authors' reply
Watt, M., Mealing, S., Eaton, M., Sculpher, M., Brasseur, P., Busca, R., Piazza, N., Palmer, S. & Moat, N., 1 Aug 2012, In: Heart. 98, 15, 1 p.
Research output: Contribution to journal › Letter › peer-review

Research output